- Home
- EXAS vs AU Comparison
EXAS vs AU Comparison
Compare EXAS & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- AU
- Stock Information
- Founded
- EXAS 1995
- AU 1944
- Country
- EXAS United States
- AU United States
- Employees
- EXAS N/A
- AU N/A
- Industry
- EXAS Medical Specialities
- AU Precious Metals
- Sector
- EXAS Health Care
- AU Basic Materials
- Exchange
- EXAS Nasdaq
- AU Nasdaq
- Market Cap
- EXAS 10.5B
- AU 10.3B
- IPO Year
- EXAS N/A
- AU 1972
- Fundamental
- Price
- EXAS $51.74
- AU $27.31
- Analyst Decision
- EXAS Strong Buy
- AU Hold
- Analyst Count
- EXAS 16
- AU 5
- Target Price
- EXAS $72.80
- AU $31.75
- AVG Volume (30 Days)
- EXAS 2.2M
- AU 2.4M
- Earning Date
- EXAS 02-19-2025
- AU 11-07-2024
- Dividend Yield
- EXAS N/A
- AU 1.50%
- EPS Growth
- EXAS N/A
- AU N/A
- EPS
- EXAS N/A
- AU 1.34
- Revenue
- EXAS $2,692,328,000.00
- AU $5,299,000,000.00
- Revenue This Year
- EXAS $11.81
- AU $31.38
- Revenue Next Year
- EXAS $11.52
- AU $28.36
- P/E Ratio
- EXAS N/A
- AU $20.34
- Revenue Growth
- EXAS 11.91
- AU 17.78
- 52 Week Low
- EXAS $40.62
- AU $15.80
- 52 Week High
- EXAS $79.62
- AU $32.57
- Technical
- Relative Strength Index (RSI)
- EXAS 35.28
- AU 64.24
- Support Level
- EXAS $49.79
- AU $25.26
- Resistance Level
- EXAS $60.88
- AU $27.62
- Average True Range (ATR)
- EXAS 2.67
- AU 0.60
- MACD
- EXAS -0.59
- AU 0.46
- Stochastic Oscillator
- EXAS 17.58
- AU 94.00
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.